JAMA Authors Warn LDT Legal Defeat Brings Risk for Labs

CLINICAL LABORATORY AND ANATOMIC PATHOLOGY LEADERS WILL WANT TO NOTE will a recent JAMA Health Forum article that strikes a cautionary tone about the future of laboratory developed test (LDT) regulation. The piece argued that the recent federal court decision striking down the Food and Drug Administration’s (FDA) LDT final rule could have unintended consequences […]

To access this post, you must purchase The Dark Report.

JAMA Authors Warn LDT Legal Defeat Brings Risk for Labs

Debate centers on whether the FDA lost long-term influence after the LDT court decision

Comments

TABLE OF CONTENTS

Need A Group Membership? Company Discounts are Available!

You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

You have read 0 of 1 of your complimentary articles this month